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Introduction
Malaria remains one of the most common and deadly parasitic diseases in the world. The World Health Organization estimates that 5-9% of the global population is infected by malaria annually, resulting in over 700,000 deaths 1 . Children under the age of five are most vulnerable to P. falciparum, the most lethal species among four malaria parasites that commonly infect humans. Malaria also takes an enormous economic toll by impacting the economies of most endemic countries, particularly in Sub-Saharan Africa. Historically, vaccines have been one of the most effective means of controlling infectious diseases. Accumulating evidence suggests that a malaria vaccine can be developed 2, 3 ; however, most malaria vaccine candidate antigens have suffered limitations of low immunogenicity and efficacy. To date, no licensed vaccine exists for malaria despite the urgent global need.
Clinical manifestation and mortality in malaria is directly associated with the blood stage of the parasite life cycle. The invasion process consists of multiple molecular events during which RBC membrane proteins and merozoite coat proteins are engaged in specific receptor-ligand interactions to form unique invasion pathways 4, 5 . Continued interest in developing a multi-antigen malaria vaccine has drawn much attention on parasite proteins localized on the surface and at the apical end of the merozoite as potential vaccine candidates 4 . Merozoite surface protein 1 (MSP1) is a major ligand coating the surface of merozoites in all species of malaria 6 , and is considered one of the leading candidates for inclusion in a multi-subunit vaccine against For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From malaria 7 . People living in malaria endemic areas carry MSP1 specific antibodies in the blood 8 , and immunization of mice with P. yoelii MSP1 protects the animals from otherwise lethal P. yoelii challenge 9 . MSP1 undergoes extensive proteolytic processing either during schizogony or soon after the merozoite release from infected RBCs 10 . Four major proteolytic fragments of P. falciparum MSP1 include 83 kDa, 30 kDa, 38 kDa, and 42 kDa, which remain associated as a non-covalent complex at the merozoite surface. The secondary proteolytic processing of the 42 kDa fragment results in the generation of 33 kDa and 19 kDa fragments. During the invagination phase of parasite entry, all MSP1 fragments are shed from the merozoite surface except the 19 kDa fragment, which remains attached to the merozoite surface through its GPI anchor, and eventually enters the RBC and modulates specific intracellular functions 11 . Our previous studies demonstrated a biochemical and functional interaction between P. falciparum 42 kDa and 19 kDa fragments of MSP1 and host RBC band 3 12, 13 . The obligatory role of MSP1 in malaria parasite invasion of RBCs 14 suggests that other MSP1 segments may recognize cognate host receptors, thus serving as targets of an effective immune response against malaria.
In this study, using a P. falciparum phage display library screen, we identified a novel region of MSP1 that directly binds to host RBC glycophorin A (GPA). Both in vitro and in vivo evidence supports a functional role of the newly identified ligand-receptor interaction during merozoite invasion of red blood cells. Together, our results suggest an essential role of MSP1-Glycophorin A-Band 3 complex during the malaria parasite invasion of red blood cells.
Materials and Methods

General methods, MSP1 constructs, and recombinant fusion proteins
All studies were IACUC approved. P. falciparum FCR3 strain was maintained in continuous culture according to standard conditions 15 . The phage library screen against purified glycophorins was performed as described previously 16 . We used a bacteriophage display library constructed from P. falciparum cDNA and cloned into a T7Select10-3 Orient Express TM vector. Phage particles were propagated in BLT5403 E. coli strain to express the phage clones containing malaria proteins on the capsid surface for biopanning experiments. Multiple rounds of biopanning were performed on both intact human erythrocytes, and purified immobilized glycophorins. Eluted phage particles were amplified in E. coli BLT5403 strain, and the supernatant was used for biopanning. Specific phage clones were identified via PCR amplification of individual plaques. The N-terminal fragment of MSP1 (MSP1 83A ) (58-939 base pairs) was PCR amplified from P. falciparum (FCR3) genomic DNA using the primers 5′-GCCGGATCCGTAACACATGAAAGTTATC-3′ (sense, BamHI) and 5′-GCCGTCGACAAGTAATTCCTTAATGTTT-3′ (antisense, SalI). The C-terminal fragment of MSP1 (MSP1 83B ) (940-2007 base pairs) was amplified using the primers 5′-GCCGGATCCGATAAGATAAATGAAATT-3′ (sense, BamHI) and 5′-GCCGTCGACTTTTAATTTATCTACTTCT-3′ (antisense, SalI). PCR products were digested with BamH1 and Sal1 and ligated in pET32a expression vector, respectively. The recombinant MSP1 83A and MSP1 83B were expressed in E. coli BL21 (DE3) as fusions to the Thioredoxin(TRX) and His tag, and fusion proteins were affinity-purified using the S protein-agarose beads. A 141-bp (631-771 bp encoding 47 amino acids) region of MSP1 83A (named here as MSP1 5kDa or MSP1 5 ) was amplified from MSP1 83A and cloned into pGEX-6P-2 using the primers 5′-GCCGGATCCCTTAAAAAACTTG TGTTC-3′ (sense, BamHI) and 5′-GCCGTCGACAATTGTTTTCTTACTTTC-3′ (antisense, SalI). A 309-bp region (103 amino acids) of MSP1 83A (named here as MSP1 12kDa or MSP1 12 ) was amplified from MSP1 83A and cloned into pET32a using primers 5′-GCGGATCCCTTAAAATTCGTGCAAATGAATTA-3′ (sense, BamHI) and 5′-GCGTCGACTAAAGTGTCAATACGTTTTTCTAA-3′ (antisense, SalI). Recombinant proteins were purified using ProBond Nickel-chelating resin (Life Technologies). Recombinant proteins TRX, MSP1 were dialyzed against 300 mM NaCl, 20 mM HEPES pH 7.4, 0.5 mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 5% Glycerol whereas GST, GST-GPA* and GST-GPA o were dialyzed against 50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 0.5 mM DTT, 1% Glycerol. All proteins were sterile filtered prior to invasion assays.
Glycophorin and RBC binding assays
TRX-MSP1 83A , TRX-MSP1 83B, and TRX proteins were mixed with 7. A polyclonal antibody against the cytoplasmic domain of GPC 18 was used in the immunoblotting assays. The RBC binding assays were performed with 20 μ L of fresh intact human erythrocytes in a buffer containing 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1.0 mM EDTA, 2.5 mM MgCl 2 , 2.0 mM DTT, and 1 % glycerol. Binding was performed at 37ºC for 2 hours, erythrocytes were washed three times in 1.0 mL of buffer, and bound proteins were eluted using 2.0 M NaCl. Binding assays using polypeptide regions of GPA were performed by immobilizing the GST, GST-GPA*, and GST-GPA o on glutathione beads. MSP1 12 was incubated in 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 2.5 mM MgCl 2 , 1.0 mM EDTA, 0.1% NP-40, 2.0 mM DTT and 1.0 mg/mL BSA for 2 hours at room temperature. Beads were washed three times and eluted in SDS sample buffer and analyzed by immunoblotting. TRX was used as a negative control.
RBC ghosts pull-down and invasion assays
MSP1 12 (TRX as control) was incubated with 40 μ l of human RBC ghosts in 1% BSA (RPMI) for 1 hour at 4°C. Ghosts were centrifuged at 18,000 X g for 10 min at 4°C, and pellet was solubilized in modified RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 1% NP-40, 0.5 mM DTT, 0.1 mM PMSF, and P8340 protease inhibitor cocktail from Sigma). Lysate was added to 25 μ l of Ni beads for 2 hours at 4°C, and proteins bound to beads were eluted and analyzed by immunoblotting. Parasites used in the invasion assays were synchronized twice using 5% sorbitol treatment to isolate ring stage parasites. Synchronized P. falciparum FCR3 parasites at the schizont stage were seeded into a 96-well plate at 2% parasitemia (2% hematocrit) in 200-300 μ l of total volume. Increasing amount of recombinant protein in complete malaria media was added to infected erythrocytes and TRX protein was used as a negative control. RBC invasion occurred under standard malaria culture conditions, and samples were analyzed after 20-24 hours post invasion. It is noteworthy that the binding assays require a reducing agent (DTT) for proper MSP1 function and stability. However, when DTT is added to parasite culture, it often exerts toxic effects and significantly reduces overall parasitemia. This limitation can be controlled by using TRX and measuring relative parasitemia compared to the control. Thus, in the presence of DTT, MSP1 12 inhibited parasite invasion at high concentrations (10 μ M) relative to TRX. RBC invasion was quantified using both microscopy and flow cytometry. For microscopy, at least 1,000 RBCs were counted for each measurement. For flow cytometry, parasitemia was quantified using either propidium iodide staining (FACSCalibur) 19 or Hoechst 33342 staining (BD LSR II flow cytometer) 20 . Invasion assays were performed in triplicate.
Infection of band 3 and protein 4.2 null mice by Plasmodium yoelii 17XL
The generation and characterization of band 3 null mice has been described previously 21, 22 . Our band 3 null mouse model is unique because it selectively lacks erythroid band 3 but not its isoform in the kidney 21 . Band 3 null mice display a secondary loss of GPA and protein 4.2 in the RBC membrane 22 . Band 4.2 null mice were generously provided by Dr. Luanne Peters at the Jackson Laboratory, Maine 23 . Band 3 null and protein 4.2 null (2-3 months old) were challenged with the rodent P. yoelii 17XL infection (blood stage), essentially as described previously 24 . Wild type C57BL/6 mice and age matched heterozygous littermates were used as controls.
Results
Identification of P. falciparum proteins binding to erythrocyte glycophorins
We used phage display technology to identify parasite invasion ligands interacting with glycophorins on the human RBC surface. Previously we used the same approach to successfully identify a specific segment of P. falciparum EBL-1 binding to RBC glycophorin B 16 . The previous study revealed a functional role of a specific segment of parasite EBL-1 in RBC invasion. Thus, an analogous approach was used in this study to identify additional parasite ligands binding to human glycophorins. Glycophorins, purified from human RBCs, were used as bait to capture the phage display clones from a previously characterized P. falciparum cDNA library 25 . Along with several known malaria ligands such as EBA-175 that bind to glycophorins, we identified multiple overlapping phage clones of MSP1 that bind to immobilized glycophorins (Fig.  1A) . DNA sequencing revealed a 141-bp region encoding amino acids 204-250 located within the N-terminal 83 kDa domain of MSP1 (Fig. 1A) . In parallel, we also performed several phage display screens using both native and neuraminidase (Nm) treated RBCs. An overlapping phage clone of MSP1 containing amino acids 240-279, located within the N-terminal 83 kDa domain, was identified (Fig. 1A) . Since the entire 83 kDa domain of MSP1 was difficult to express as recombinant protein in bacteria, two smaller segments, termed MSP1 83A and MSP1 83B , were expressed. Both overlapping MSP1 phage clones that bound to glycophorins were located within MSP1 83A segment (amino acids 20-313), whereas MSP1 83B (amino acids 314-669) segment served as a negative control. In addition, we made a GST fusion protein expressing the original MSP1 phage clone 1 (amino acids 204-250) that binds to glycophorins. However, this GST fusion protein, termed MSP1 5 , showed limited solubility and was susceptible to proteolysis (Fig.  2B ). To overcome this limitation, we scanned the flanking sequences of MSP1 5 using predictive algorithms of protein secondary structure, and designed a relatively stable MSP1 12 construct (amino acids 194-296) located within the MSP1 83A domain of MSP1 (Fig. 1B) . In the initial binding assays, all recombinant fusion proteins of MSP1 were used, however, the MSP1 12 construct was found to be most effective in subsequent assays.
Interaction of MSP1 with purified glycophorin A and erythrocytes
Using recombinant MSP1 segments and purified reconstituted glycophorins, liposome-binding assays were performed to test whether MSP1 interacts with human erythrocyte glycophorins. MSP1 fusion proteins (MSP1 83A , MSP1 83B , and MSP1 12 ), containing an internal S-tag, were immobilized to S-beads and the GST-tagged MSP1 5 segment was bound to glutathione beads. Beads containing the MSP1 fusion proteins were incubated with glycophorins reconstituted as liposomes, and specific binding was quantified along with appropriate negative controls (Fig. 2) . MSP1 binding to specific glycophorins was detected using antibodies against glycophorin A and glycophorin C. Multiple segments of MSP1 termed MSP1 5 , MSP1 12 , and MSP1 83A specifically bound to GPA as compared to control TRX or GST proteins ( Fig. 2A) . In contrast, MSP1 83B showed minimal but detectable binding with GPA under these conditions, which could originate from the partial overlap of the GPA-binding region of MSP1 extending into the MSP1 83B segment. Interestingly, both MSP1 5 and MSP1 83A preferentially pulled down monomeric form of GPA, whereas the MSP1 12 segment bound to both monomeric and dimeric forms of GPA (Fig. 2B) . The purified glycophorins used contain glycophorin A, glycophorin B, and glycophorin C, which served as an additional negative control for the liposome-binding assay. For example, binding of MSP1 83A was specific to GPA as immunoblotting against glycophorin C (GPC) did not detect any binding under these conditions (Fig. 2B ). Moreover, we tested the binding of MSP1 12 with freshly harvested intact RBCs. The RBC-bound MSP1 12 was eluted with high salt and detected by immunoblotting against the TRX tag showing specific interaction between MSP1 12 and human RBCs (Fig. 2C) . Pre-treatment of RBCs by neuraminidase did not affect their binding affinity for MSP1 12 (Fig. 2C) , consistent with the observation that MSP1 clones were originally identified in a phage display screen using neuraminidase-treated RBCs as bait. Surprisingly, the MSP1 12 binding to RBCs was not affected by the pre-treatment of RBCs by trypsin, which is known to cleave a large extracellular segment of GPA 17 .
Together, these data demonstrate that a short segment located within the MSP1 83A region binds to a neuraminidase and trypsin insensitive site(s) on human RBCs. To establish a biochemical interaction between MSP1 12 and endogenous glycophorin A (GPA), a pull-down assay was performed using human RBC membranes (ghosts). Freshly isolated ghosts contain multiple species of GPA including the homodimer, heterodimer, and monomer (Fig. 2D) , consistent with published studies 26 . However, following detergent treatment of ghosts, which is required for the pull-down assays, a previously unrecognized 18 kDa species of GPA was observed (Fig. 2D , lane with NP-40 treatment) 26, 27 . It is known that solubilization of ghosts in non-ionic detergents releases and activates several proteases that may give rise to smaller species of GPA 28 . The pull-down assays demonstrated that MSP1 12 associates with several species of GPA including the homodimer, heterodimer, monomer, as well as an ~18 kDa band (Fig. 2D) . Consistent with this finding, MSP1 83A but not MSP1 83B (Fig. 1A) specifically pulled down the same species of GPA (Fig. 2D) . While the heterodimer, monomer, and 18 kDa species of GPA were pulled down with immobilized MSP1 12 in the neuraminidase and trypsin treated ghosts, the homodimer species of GPA was detected only in the untreated ghosts (Fig. 2D ). This finding is consistent with the observation that neuraminidase and trypsin treatment of ghosts eliminate the homodimer species of GPA as detected by immunoblotting. Previous studies demonstrated that neuraminidase treatment of RBCs removes the sialic acid content of GPA, and trypsin treatment removes a significant portion of the extracellular domain of GPA 17, 29 . These two treatments, in addition to chymotrypsin, are frequently used to test for receptor enzyme sensitivity on the surface of erythrocytes. Glycophorin C is also known to be at least partially sensitive to trypsin treatment that eliminates EBA-140 binding to erythrocytes 30 . Interestingly, the neuraminidase treatment of intact RBCs appears to increase the relative amount of GPA heterodimer pulled down by MSP1 12 . This observation suggests that the MSP1 12 interaction with GPA is resistant to neuraminidase treatment, and occurs independent of the presence of sialic acids on host glycophorin A.
MSP1 interaction with endogenous glycophorin A
MSP1 binds to a unique region of human glycophorin A
While human erythrocyte GPA is considered trypsin-sensitive, this treatment is known to leave a short membrane-proximal extracellular segment of GPA on the RBC surface. Trypsin treatment of intact RBCs releases peptides of 31 and 39 amino acids from GPA 17 . These two peptides correspond to the Arg 31 and Arg 39 (Fig. 3A) , thus leaving ~40 amino acids exposed on the RBC surface after trypsin treatment. This short ectodomain peptide is contiguous to the single transmembrane domain of GPA consisting of amino acids 72-94. While the 10F7 mAb directed against the extracellular domain of GPA does not recognize the antigen in ghosts prepared from trypsin-treated RBCs, the polyclonal antibody raised against the cytoplasmic C-terminus of GPA recognizes several smaller species of GPA following trypsin treatment of intact RBCs (Fig. 3B) . We hypothesized that this trypsin-resistant segment of the extracellular domain of GPA is in fact responsible for mediating the binding of MSP1 12 with RBCs. Guided by the known trypsin cleavage sites of GPA, and combined with a topological model of GPA, we expressed the putative MSP1 binding region of GPA (amino acids 31-72) (Fig. 3A) , herein referred to as GPA* 17, 31 . This short segment was expressed as
GST-GPA* fusion protein and used for the binding assays (Fig. 3C) . The pull-down experiments demonstrated specific binding of MSP1 12 to the trypsin-resistant extracellular domain of GPA* (Fig. 3C) . Moreover, to demonstrate specificity, we expressed the amino-terminal segment of GPA encoded by amino acids 1-30 designated as GST-GPA o . Unlike GST-GPA*, the GST-GPA o fusion protein did not bind to MSP1 12 (Fig. 3C) . This observation is consistent with our conclusion that MSP1 12 interaction with human RBCs is sialic acid independent (SAID) since the recombinant proteins expressed in bacteria are devoid of sialic acid residues.
Functional role of MSP1-Glycophorin A interaction
We tested the activity of MSP1 83A and MSP1 12 to inhibit P. falciparum invasion of human RBCs. Both N-terminal segments of MSP1 partially inhibited parasite invasion in human RBCs achieving up to ~40% inhibition of P. falciparum invasion in human RBCs under defined experimental conditions at high protein concentration. This observation is consistent with previous studies providing strong evidence that MSP1 83 inhibits parasite invasion. For example, in one study a peptide synthesized within the MSP1 12 region of MSP1 83 significantly inhibited RBC invasion 32 . In a separate study, antibodies against the MSP1 83 domain potently inhibited malaria invasion and growth relative to other domains of MSP1 33 . Similarly, another study tested the activity of purified erythrocyte glycophorins and demonstrated a significant inhibitory effect on parasite invasion 34 . Enzyme treatment of RBCs prior to glycophorin purification altered invasion inhibitory activity of purified glycophorins. Interestingly, glycophorins isolated from trypsinized RBCs maintained a significant inhibitory activity indicating that the trypsin-resistant regions of RBC glycophorins play a significant role in P. falciparum parasite invasion of RBCs 34 . Thus, the trypsin-resistant region of GPA, as identified in this study as an interacting segment with MSP1 12 region is likely to perform a functional role during malaria parasite invasion.
Glycophorin A deficient band 3 null erythrocytes are resistant to malaria infection
We generated band 3 null mice that were completely deficient in erythroid band 3 21 . As a consequence of band 3 loss, the mature RBC membrane also showed a secondary loss of GPA and protein 4.2 21, 22 . Based on our previous findings showing a functional interaction between the carboxyl-terminus of MSP1 and band 3 12 , we examined the possibility that RBCs lacking both band 3 and GPA may be resistant to malaria infection. The band 3 null mice lacking erythrocyte band 3, GPA, and protein 4.2 complex are completely resistant to invasion by a virulent strain of murine malaria, P. yoelii 17XL (Fig. 4A) . Band 3 null mice, lacking GPA and protein 4.2 (n=4), did not display any patent parasitemia, whereas wild type mice succumbed to infection in 7-9 days. The rate of parasite infection in the mutant heterozygous mice was similar to that in wild type littermates (Fig. 4A) . To detect any subpatent infection in the band 3 null mice, blood collected from the band 3 null mice on day 14 following inoculation was transferred to wild type mice (n=4). None of the sub-inoculated mice developed malaria infection, indicating that there were no viable parasites present in the band 3 null mice, which were not evident in the peripheral blood smears or flow cytometry. Further, the serum prepared from the band 3 null mice had no inhibitory effect on the in vitro culture of P. yoelli 17XL in wild type murine RBCs at least for 24 hours, indicating that the cause of the protection from P. yoelli 17XL in band 3 null mice is unrelated to the composition of the blood serum. In contrast, protein 4.2 null mice 23 did not show any inhibition of parasitemia when challenged with P. yoelii 17XL (Fig. 4B) . These results indicate that deficiency of the band 3-glycophorin A-protein 4.2 complex in the mouse RBC membrane is sufficient for complete resistance to P. yoelii 17XL invasion of RBCs. It is noteworthy that a previous study used GPA null mice, which retain erythrocyte band 3, to demonstrate that GPA is not required for lethal P. yoelii 17XL infection 35 . Therefore, it appears that GPA alone is not essential, but in combination with Band 3, this complex is required for malaria infection in vivo. Interestingly, the GPA null mice showed reduced parasitemia and improved survival when challenged with Babesia rodhaini, a parasite homologous to malaria, thus indicating a functional role of GPA in Apicomplexan parasite invasion 36 .
To further investigate the role of the host Band 3-GPA complex in the P. falciparum invasion process, we tested the susceptibility of band 3 null mouse RBCs to P. falciparum (3D7 strain) invasion in vitro. When infected with synchronized P. falciparum trophozoites, RBCs from both wild type and band 3 heterozygous mice showed a typical invasion profile after 24 hours post-invasion (Fig. 4C) , consistent with previous studies 37 . However, the band 3 null RBCs lacking both GPA and protein 4.2 did not show any new infection (rings) by P. falciparum (Fig. 4C) . Band 3 null mouse RBCs remained essentially intact in the culture as judged by smear during the course of the experiment (Fig. 4D) . This observation suggests that the increased fragility of mutant RBCs is unlikely to be the reason for their resistance to malaria infection. To our knowledge, no experimental model system exists where the deficiency of band 3-GPAprotein 4.2 complex can be investigated in structurally normal red blood cells.
Discussion
Development of an effective subunit vaccine against malaria requires a precise description of the mechanism by which the merozoites invade host red blood cells. The invasion process consists of a sequence of events where the merozoite coat proteins are engaged with host RBC membrane proteins in specific ligand-receptor interactions to form unique invasion pathways. One of the most abundant ligands coating the entire surface of the merozoite is merozoite surface protein-1 (MSP1), a highly conserved protein across multiple parasite species 6 . MSP1 is essential for parasite invasion of RBCs, and its genetic disruption is lethal 4, 38 . The detection of antibodies against the MSP1 19 segment in an infected host triggered an intense scrutiny of MSP1 as a potential malaria vaccine candidate 8 . Despite these efforts, the MSP1 19 based vaccine efforts have only produced partial protection, suggesting the involvement of other MSP1 domains and/or associated proteins in the invasion process. Therefore, a better understanding of MSP1 interactions is essential for the development of an effective vaccine against malaria.
Early studies on P. falciparum MSP1 have shown its interaction with both human and Saimiri monkey RBCs in a sialic acid-dependent manner 39 . However, separate studies used peptides derived from P. falciparum MSP1 83 , MSP1 42 , and MSP1 38 domains and demonstrated that these peptides can bind to sialic acid-depleted human RBCs with relatively high affinity 32 . Consistent with these findings, our previous work showed that MSP1 19 interacts with host band 3 receptor mediating parasite invasion of RBCs via the sialic acid independent invasion (SAID) pathway 12, 13, 40 . Host band 3 is the most abundant membrane protein in RBCs, and forms a tight stoichiometric complex with glycophorin A (GPA). Like band 3, GPA is also highly abundant and serves as a sialic acid-dependent receptor (SAD) binding the parasite ligand EBA-175 29, 41 . Based on these observations, we hypothesized that merozoites may display ligands that can potentially bind to both band 3 and GPA simultaneously, thus integrating distinct invasion pathways. In this study, we employed several phage display screening strategies to identify a unique sequence located within the amino-terminal 83 kDa domain of MSP1 that directly binds to a peptide segment located within the extracellular domain of GPA (Fig. 3) . MSP1 12 , which includes the GPA-binding sequence, interacts with purified as well as endogenous GPA and recognizes multiple species of GPA (Fig.  2) . Together, our findings reinforce the possibility that a specific peptide sequence of MSP1 could function as a potent inhibitor of malaria parasite invasion of human RBCs. Interestingly, antibodies targeting the trypsin-resistant region of GPA, a region that overlaps with the MSP1 12 binding site (Fig. 3A) , caused a pronounced effect on RBC membrane rigidity 42, 43 . It was concluded that the increase in membrane rigidity requires a ligand-induced interaction with GPA that subsequently alters the RBC cytoskeletal interactions 43 . Thus, MSP1 12 binding to GPA may also alter the RBC membrane properties during parasite invasion. Similarly, a separate study found that reduced RBC membrane deformability upon GPA engagement correlated with reduced malaria parasite invasion 44, 45 . This finding raises the possibility that MSP1 12 binding to GPA may function by altering the RBC membrane properties during parasite invasion.
A recent study reported identification of two novel proteins, MSPDBL1 and MSPDBL2, associated with MSP1 46 . However, this study did not detect a direct interaction of MSP1 with human RBCs. In our view, this discrepancy could originate from the protein preparations used in that study. A full-length recombinant MSP1 assembled by tandem tethering of respective MSP1 fragments was used for the RBC binding assays 46 . Due to the poor solubility, recombinant full length MSP1 was subjected to denaturation and renaturation steps likely resulting in the loss of conformational folding and protein binding activity. In our experience, recombinant MSP1 is best expressed as soluble sub-domains without subjecting them to denaturation-renaturation steps (Fig. 1) . Given the putative redundancy among parasiteligand binding partners, it is likely that several interactions occur during the initial merozoite adhesion process presumably involving multiple host receptors. Indeed, previous studies have predicted a close proximity of band 3, involving its 12 TM domains, with the TM domain of GPA, and it was shown that Glu-658 of band 3 is required for its association to GPA 31, 47 . Similarly, topology models predicting the association of band 3 with GPA place the region of band 3, which binds to MSP1 19 , and MSP1-binding region of GPA (GPA*) adjacent to each other within the RBC membrane (Fig. 5A ) 12, 47 . Based on these observations, our results support a model where MSP1 and its associated protein complex 13 anchors the merozoite on the RBC surface by engaging with two distinct closely-apposed binding sites located within the surface exposed domains of band 3 and GPA (Fig. 5) . This receptor and co-receptor complex is likely to give rise to redundancy while also mediating the adhesion and re-orientation steps of the merozoite during invasion.
In P. falciparum invasion of RBCs, glycophorin A was identified as the first RBC receptor binding the merozoite EBA-175 in the sialic acid dependent manner 41, 48 . Human En(a-) RBCs lacking GPA, and M k M k RBCs lacking both GPA and glycophorin B (GPB), confer partial resistance to P. falciparum invasion [49] [50] [51] . A short hairpin RNAbased knockdown GPA in CD34 + stem cells generated GPA-deficient erythrocytes showing partial reduction of P. falciparum invasion by the sialic acid-dependent strains 52 . In contrast, several previous studies have shown that the majority of the inhibitory effect of GPA on malaria invasion stems from its polypeptide backbone and not its sialic acid content 34, [53] [54] [55] . Using a recombinant trypsin-resistant peptide of GPA that binds to a peptide sequence within MSP1 83A (Fig. 3A) , our findings provide definitive evidence that GPA functions as a host receptor via the sialic acid-independent pathway. Future studies will determine how the co-occupancy of GPA by two major malaria ligands MSP1 and EBA-175 is regulated during the RBC invasion process.
Host erythrocyte GPA serves as an important receptor that is necessary but not sufficient for malaria invasion of human RBCs. Stable incorporation of GPA in the human RBC membrane requires the presence of band 3 protein, as both mouse and human RBCs genetically lacking band 3 also show a secondary loss of GPA 22, 56, 57 . The existence of a tightly bound Band 3-GPA complex in the RBC membrane suggests that the merozoite may exploit this complex to provide some measure of redundancy by switching between the sialic acid dependent and independent pathways during invasion. Our findings showing complete resistance of band 3 and GPA deficient mouse RBCs to malaria infection both in vivo and in vitro (Fig. 4) lends further support to this model. Genetic abnormalities of human RBC band 3 are known to provide resistance to malaria infection [56] [57] [58] . For example, band 3 mutation in South-East Asian Ovalocytosis (SAO) confers partial resistance malaria infection. Despite multiple explanations including the RBC membrane rigidity, cytoskeletal stiffness, and metabolic imbalance, a precise molecular mechanism of malaria resistance in SAO erythrocytes remains poorly understood. Our findings raise the possibility that some of the altered properties of SAO erythrocytes could originate from aberrant GPA interaction with SAO band 3.
Band 3 and GPA constitute the most abundant membrane proteins on the surface of RBCs, whereas parasite MSP1 represents the most abundant merozoite surface protein. This receptor-ligand expression pattern is consistent with the merozoite's ability to adhere to RBCs regardless of its orientation. Hence, we propose a model where multiple subunits of MSP1 bind to the Band 3-GPA complex during the initial adhesion stage of the invasion process (Fig. 5) . This initial adhesion step is then followed by the engagement of additional ligand-receptor interactions thus facilitating the parasite re-orientation and penetration in erythrocytes. Upon merozoite entry into For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From RBCs, the bulk of MSP1 complex is released from the merozoite surface. Our model also provides a rationale for the exquisite selectivity of the merozoite's preference for RBCs in circulation since the Band 3-GPA complex is not expressed in other blood cells. 5 ) were immobilized to S-beads (or Glutathione beads) and incubated with glycophorin-containing liposomes. Bound proteins were detected by immunoblotting. The TRX fusion protein containing an S-tag and GST were used as negative controls. MSP1 12 showed specific binding to GPA relative to control in both the monomer (lower band) and dimer species of GPA (upper band). Binding of GPA dimer was detected under mild conditions of beads washings whereas the GPA monomer binding was observed under both mild and stringent conditions. GPA binding to MSP1 83A , and a very faint signal to MSP1 83B was also observed. (B) Immunoblotting against glycophorin C (GPC) did not detect any signal to either MSP1 83A or MSP1 83B fusion proteins. (C) RBC binding assay. Bound proteins were eluted by high salt and detected by immunoblotting. MSP1 12 showed specific binding to RBCs irrespective of their treatment with trypsin (T), chymotrypsin (Ch), and neuraminidase (Nm). Untreated RBCs (Un) were used as control. (D) Detection of GPA species in the detergentsolubilized human RBC ghosts by immunoblotting. Four specific bands of GPA were detected corresponding to homodimer, heterodimer, monomer, and a previously unrecognized 18 kDa band in the NP-40 solubilized ghosts. Immunoblotting using a polyclonal antibody against GPA showed specific binding of MSP1 12 and MSP1 83A but not MSP1 83B to multiple species of GPA. ) was also expressed and tested under identical conditions. Since both fusion proteins contained the GST tag, GST was also used as a negative control. 
